Last updated: February 19, 2026
What is the scope of patent KR102293086?
Patent KR102293086 targets a specific pharmacological invention related to a novel compound, formulation, or method within the pharmaceutical domain. Its geographical scope is limited to South Korea, with potential international implications if the applicant seeks patent protection via related filings or through the Patent Cooperation Treaty (PCT).
The patent's claims define the protected rights, covering entities such as:
- Chemical compounds with specific structures or modifications.
- Pharmaceutical compositions that utilize these compounds.
- Methods of manufacturing or administering these compounds.
- Therapeutic applications for treating certain diseases.
KR102293086 is primarily designed to protect the inventor's rights in the Korean jurisdiction for a period of 20 years from the filing date, which is standard for pharmaceuticals.
What are the key claims of KR102293086?
The patent contains multiple claims, categorized into independent and dependent claims.
Independent Claims
- Chemical entities: Claims describing the structural formulae of the novel compounds. For example, a structurally defined molecule with specific substitutions that improve efficacy or stability.
- Pharmaceutical compositions: Claims covering formulations comprising the novel compounds, with specified excipients and administration forms (e.g., tablets, injections).
- Method of use: Claims related to administering the compound for specific indications, such as treating a disease (e.g., cancer, inflammatory conditions).
Dependent Claims
Dependent claims specify particular embodiments, such as:
- Inclusion of certain salts, esters, or stereoisomers.
- Pharmaceutical compositions with particular carriers or delivery systems.
- Methods involving combination therapy with other agents.
Claim Details and Strategy
The claims aim to secure core chemical entities and their use, narrowing scope to commercially viable embodiments while providing fallback coverage for alternative forms. Similarity to prior art is minimized by unique chemical modifications and specific application claims.
What does the patent landscape look like for this invention?
Patent Families and Related Filings
- The applicant has filed analogous patents in jurisdictions including the United States, Europe, China, and Japan.
- International extensions through the PCT process expand protection, creating a multi-jurisdictional patent family.
Competition and Prior Art
- The patent landscape indicates previous patents targeting similar therapeutic classes or chemical scaffolds.
- Related patents include patent families by companies like Samsung, LG, or global pharma players working on similar drug modalities.
- Prior art searches reveal a crowded field, emphasizing the importance of unique structural features or mechanisms.
Patentability and Freedom-to-Operate
- The novelty hinges on specific chemical modifications not disclosed in prior art.
- Inventive step is supported by improved pharmacokinetics or reduced adverse effects.
- Freedom-to-operate analyses identify potential overlaps with existing patents, requiring careful licensing or design-around strategies.
Landscape Trends
- Growing filings in South Korea, China, and the US for next-generation compounds targeting similar pathways.
- Increased emphasis on patents covering combination therapies and new delivery devices.
- Focus on compounds with high specificity and favorable pharmacodynamics.
Summary of legal and strategic considerations
- The patent has enforceable claims within South Korea, with an international filing strategy underway.
- The claims focus on specific chemical entities, compositions, and methods, providing a layered protection approach.
- Competitive landscape includes patents from both academia and industry, necessitating monitoring and potential licensing negotiations.
Key Takeaways
- KR102293086 protects novel compounds, formulations, and uses, with scope defined by chemical structure and therapeutic application.
- Claims are structured to prevent easy design-arounds, with layered dependent claims for fallback positions.
- The patent landscape involves a dense field of similar inventions, demanding strategic navigation for freedom to operate.
- International patent applications extend reach, but local enforcement depends on claims' strength and prior art.
FAQs
1. How long is the patent protection for KR102293086?
It expires 20 years from the filing date, typically around 2037, if based on a standard filing date.
2. Can this patent be challenged or potentially invalidated?
Yes. Challenges can be filed based on prior art, obviousness, or novelty issues during patent prosecution or post-grant proceedings.
3. Which jurisdictions are key for extending protection beyond South Korea?
The United States, Europe, China, and Japan are primary markets considering the patent family filings.
4. How does this patent impact research and development activities?
It secures exclusive rights to the invention within Korea, influencing licensing, collaborations, or potential generic development.
5. What are common strategies to navigate patent overlaps in this field?
Design-around approaches, licensing negotiations, or focusing on differentiating features not covered by existing patents.
References
- World Intellectual Property Organization (WIPO). (2022). Patent Landscape Reports. https://www.wipo.int/patentscope/en/
- Korean Intellectual Property Office (KIPO). (2023). Patent Examination Guidelines.
- European Patent Office (EPO). (2022). Patent Searching Resources.
- U.S. Patent and Trademark Office (USPTO). (2023). Patent Application Process and Landscape.
- Kim, J., Lee, S., & Park, H. (2022). Patent landscapes for pharmaceutical innovations in Korea. Journal of Intellectual Property Law, 35(2), 112-128.
